QT
FULC icon

Quantamental Technologies’s Fulcrum Therapeutics FULC Stock Holding History

Quantamental Technologies’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-11,855
Closed -$39.1K – 410
2023
Q2 		$39.1K Sell
11,855
-300
-2% -$881 0.02% 448
2023
Q1 		$34.6K Buy
+12,155
New +$109K 0.02% 398

Other funds holding FULC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Quantamental Technologies's FULC Position: Q3 2023 in Review

Quantamental Technologies sold out of Fulcrum Therapeutics (FULC) in Q3 2023, closing a stake of 11,855 shares — an estimated $39.1K sold.

Quantamental Technologies first reported a position in FULC in Q1 2023 and held it in 2 quarters. The position peaked at $39.1K in Q2 2023. 81 funds tracked by Wall St. Rank hold FULC as of Q3 2023.

  • Quantamental Technologies reported no remaining Fulcrum Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Quantamental Technologies sold 11,855 Fulcrum Therapeutics shares in Q3 2023, an estimated $39.1K.
  • Quantamental Technologies first reported a position in Fulcrum Therapeutics in Q1 2023 and held it in 2 quarters.
  • Quantamental Technologies's Fulcrum Therapeutics position peaked at $39.1K in Q2 2023.
  • 81 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q3 2023.

Based on Quantamental Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.